NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/16/2026
Back to search
Official data from USPTO
ORUKA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/16/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
07/15/2024
Registration date
06/16/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/01/2025
First use in commerce
12/01/2025
Drawing code
4
Owner type
03
Owner location
Menlo Park, CA, US
Examiner
YOUNG, CARRIE SKYE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Oruka Therapeutics, Inc.
Representatives
Nichole T. Hayden Nelson Mullins Riley & Scarborough LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical preparations for scientific purposesin vitro scientific or research use; Biochemicalsmonoclonal antibodies for in vitro scientific or research use
Class 5
Biologics in the nature of pharmaceutical preparations for treatment of chronic skin diseases such as plaque psoriasispsoriatic arthritisother dermatologic and inflammatory indications; Antibodies for medical purposesfor treatment of chronic skin diseases such as plaque psoriasispsoriatic arthritisother dermatologic and inflammatory indications; Therapeutic pharmaceutical for the treatment of chronic skin diseases such as plaque psoriasispsoriatic arthritisother dermatologic and inflammatory indications
Class 42
Biotechnology research related to antibodies and therapies for treatment of chronic skin diseases such as plaque psoriasispsoriatic arthritisother dermatologic and inflammatory indications
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/27/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/27/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/05/2026
IUAF
USE AMENDMENT FILED
12/17/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/17/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/13/2025
EX1G
SOU EXTENSION 1 GRANTED
12/12/2025
EXT1
SOU EXTENSION 1 FILED
12/12/2025
EEXT
SOU TEAS EXTENSION RECEIVED
12/12/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/22/2025
PUBO
PUBLISHED FOR OPPOSITION
04/22/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/16/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/27/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/26/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/14/2025
GNRT
NON-FINAL ACTION E-MAILED
01/14/2025
CNRT
NON-FINAL ACTION WRITTEN
01/14/2025
DOCK
ASSIGNED TO EXAMINER
12/31/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2024
NWAP
NEW APPLICATION ENTERED
07/15/2024
Continuous trademark protection
Get notified about every new filing that threatens ORUKA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.